Item 5. Other Information
Item
5. Other Information
None .
Item
6. Exhibits
The
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.
Exhibit
No.
Description
31.1*
Certification
of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section
302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification
of Principal Accounting and Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**
Certification
of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
32.2**
Certification
of Principal Accounting and Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
101.INS*
Inline XBRL
Instance Document
101.SCH*
Inline XBRL
Taxonomy Extension Schema Document
101.CAL*
Inline XBRL
Taxonomy Extension Calculation Linkbase Document
101.DEF*
Inline XBRL
Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL
Taxonomy Extension Labels Linkbase Document
101.PRE*
Inline XBRL
Taxonomy Extension Presentation Linkbase Document
104*
Cover Page
Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)
*
Filed herewith.
**
Furnished herewith. This certification is
being furnished solely to accompany this report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section
18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filings of the Company, whether made
before or after the date hereof, regardless of any general incorporation language in such filing.
22
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
ANEW
MEDICAL, INC.
Date: August
19, 2024
By:
/s/
Joseph A.
Sinkule
Name:
Joseph A.
Sinkule
Title:
Chief Executive
Officer
(Principal
Executive Officer)
Date: August
19, 2024
By:
/s/
Jeffrey
LeBlanc
Name:
Jeffrey
LeBlanc
Title:
Chief
Financial Officer
(Principal
Accounting Officer)
23
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.